Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 14/20 | 0.50 |
| ▸ | MAOA | P21397 | 13/20 | 0.50 |
| ▸ | ESR1 | P03372 | 3/20 | 0.45 |
| ▸ | CYP27A1 | Q02318 | 1/20 | 0.41 |
| ▸ | CYP24A1 | Q07973 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30769016 | 0.94 | MAOB (0.44) | MAOBMAOAESR1CYP27A1CYP24A1 | |
| SCHEMBL30724068 | 0.87 | ESR1 (0.60) | MAOBMAOAESR1 | |
| SCHEMBL5852029 | 0.83 | MAOB (0.57) | MAOBMAOAESR1MAPTHRH3 | |
| SCHEMBL30769201 | 0.82 | EBP (0.52) | MAOBMAOAESR1CYP24A1HRH3 | |
| SCHEMBL30723754 | 0.80 | MAOB (0.48) | MAOBMAOAESR1CYP24A1ALDH1A1 | |
| SCHEMBL30768559 | 0.79 | MAOB (0.41) | MAOBMAOAESR1CYP24A1HRH3 | |
| SCHEMBL23297257 | 0.78 | EBP (0.51) | MAOBMAOAESR1CYP27A1MAPT | |
| SCHEMBL30769328 | 0.78 | MPO (0.46) | MAOBMAOACYP24A1ALDH1A1HRH3 | |
| SCHEMBL30769413 | 0.74 | MAOB (0.48) | MAOBMAOACYP24A1HRH3 | |
| SCHEMBL5852025 | 0.72 | ESR1 (0.72) | MAOBMAOAESR1MAPTHRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024006776-A1 | ESTROGEN RECEPTOR ALPHA DEGRADERS AND MEDICAL USE THEREOF | RELAY THERAPEUTICS, INC. (US) | 2024-01-04 | — | — | WO | disclosed |